Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 March 2024 | Story Valentino Ndaba | Photo SUPPLIED
Prof Robert Peacock
Prof Robert Peacock, of the University of the Free State’s (UFS) Criminology Department, champions global engagement in scholarship, offering hope to victims worldwide while linking academia, policy, and practice.

Crime and victimisation have far-reaching consequences that profoundly impact on societal, economic, and ecological development. At the forefront of addressing these global challenges in Criminology, Victimology, Transitional and Criminal Justice, stands Prof Robert Peacock, an esteemed figure in the field from the University of the Free State's Department of Criminology.

His expertise adds significant depth to understanding and tackling the complex interplay between interpersonal conflict and broader societal, economic and ecological injustices. As serving and now Immediate Past President of the World Society of Victimology, Prof Peacock’s impact reached the highest levels, holding consultative status at both the United Nations Economic and Social Council and the Council of Europe. Together with the Justice Section of the United Nations Office on Drugs and Crime (UNODC), interventions on Crime Prevention and Criminal Justice reform were also made on occasion of the 35th Anniversary of the United Nations Declaration of Basic Principles of Justice for Victims of Crime and Abuse of Power.

Advancing global discourse

Reflecting on his tenure, Prof Peacock emphasises: “The plight of victims of crime and abuse of power underscores the imperative to scrutinise global and local power dynamics, linking local experiences to global patterns of victimisation and transformation.” This sentiment resonated profoundly during the World Victimology Symposium held in Donostia/San Sebastian in Spain, shedding light on the Anthropocene epoch’s complexities.

His commitment to international collaboration is unwavering, evident in his new role on the Scientific and Advisory committee of the upcoming 2025 World Criminology conference to be hosted by O.P. Jindal Global University in India.

Global reach

Beyond academia, Prof Peacock’s influence extends worldwide, with invitations as a guest lecturer, course director, and keynote speaker at prestigious institutions and symposia. His guest editor roles in special editions of journals like Mediarres and Ethnicity in Criminal Justice highlight his dedication to advancing critical regional and international discourse.

To proceed with an emancipatory agenda for victims of crime and abuse of power in Africa or that of a Southern Victimology, Prof Peacock advocates for a paradigm shift in victimology, transcending narrow Western perspectives, and to remain mindful of the global economy and geopolitics that create new variations of privilege and status and asymmetries that cut across nations and regions. Recent translations of his work into Spanish aim to enhance accessibility across Latin America.

Strategic collaborations

In recognition of his expertise, Prof Peacock received a Global Minds grant, facilitating collaboration with KU Leuven (Katolieke Universiteit Leuven) in Belgium, a leading institution in law and criminology. This partnership, focusing on human rights, transitional justice, restorative justice and victimology, paves the way for impactful research on conflict, peace, and development.

Prof Peacock’s longstanding collaboration with colleagues in Belgium and the Netherlands underscores his commitment to international scholarship. Together, they’ve contributed significantly to victimological approaches to international crimes, even securing an audience with Pope Francis.

Advancing practical application

In advancing praxis and the internationalisation of engaged scholarship, Prof Peacock presented twice during the month of January 2024 on the topic of Trauma informed practice for frontline workers at the Permanent Mission of Belgium to the European Union. This was done in close cooperation with the Leuven Institute of Criminology, KU Leuven, and the Belgian Ministry of Foreign Affairs in Brussels, together with an interdisciplinary project consortium, that included partners from Austria, Belgium, Croatia, Greece, Portugal, Slovakia, and Slovenia. Prof Peacock shared as speaker sessions with a Trauma Expert of the Victims and Witnesses Section of the International Criminal Court in The Hague.

As Prof Peacock continues to champion engaged scholarship on an international scale, his contributions seek to ameliorate the plight of victims of crime and abuse of power worldwide, bridging gaps between academia, policy, and practice.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept